Sex Differences in Allergic Bronchopulmonary Aspergillosis and its Impact on Exacerbations

Mycopathologia. 2024 Oct 3;189(6):90. doi: 10.1007/s11046-024-00893-8.

Abstract

The impact of sex on allergic bronchopulmonary aspergillosis (ABPA) outcomes remains uncertain. We retrospectively included ABPA subjects per the revised International Society for Human and Animal Mycology ABPA working group criteria over 13 years. We compared the clinical features, lung function, immunological tests, imaging, and ABPA exacerbation rates between men and women. Our primary objective was to assess whether women experience higher ABPA exacerbations than men. We included 731 ABPA subjects (mean age, 34.5 years; 49.5% women). Women with ABPA were older and had underlying asthma more frequently than men. There was no difference in lung function, immunological investigations, and imaging between men and women. ABPA exacerbations occurred in a slightly higher proportion of women than men (44.5% vs. 38.2%) but did not reach statistical significance (p = 0.09). We did not find a significant sex difference in ABPA exacerbation rates. Prospective studies should confirm our findings.

Keywords: Aspergillus; Allergic bronchopulmonary mycosis; Allergy; Asthma; Bronchiectasis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aspergillosis, Allergic Bronchopulmonary* / microbiology
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Respiratory Function Tests
  • Retrospective Studies
  • Sex Factors
  • Young Adult